Hallux, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.halluxinc.com
Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis
Phase 2
Active, not recruiting
- Conditions
- Onychomycosis of Toenail
- Interventions
- First Posted Date
- 2021-11-26
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Hallux, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT05135910
- Locations
- 🇺🇸
OrthoArizona - East Valley Foot & Ankle Specialists, Mesa, Arizona, United States
🇺🇸Front Range Foot and Ankle Clinic, Parker, Colorado, United States
🇺🇸Oregon Dermatology & Research Center, Portland, Oregon, United States
Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail
Phase 2
Completed
- Conditions
- Onychomycosis
- Interventions
- Drug: HTS-519 Insert
- First Posted Date
- 2016-06-14
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Hallux, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02798380
- Locations
- 🇺🇸
OrthoArizona - East Valley Foot & Ankle Specialists, Mesa, Arizona, United States
News
No news found